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To the editor,
Heterozygous beta-thalassemia (β-thal) carriers are 
characterized by microcytosis, hypochromia, and elevated 
HbA2 levels (≥3.5%) [1]. Although an elevated HbA2 level 
is a diagnostic parameter for β-thal, the interaction between 
d-globin gene mutation and β-thal can result in a normal 
HbA2 level, leading to misdiagnosis [2]. As δ-thalassemia 
(δ-thal) has no clinical significance, a reduced HbA2 level 
in β-thal carriers is an important parameter in the pres-
ence of δ-thalassemia [3]. δ-globin gene mutations (http://
globin.cse.psu.edu/hbvar/menu.html) have been reported 
[4]. HbA2-Yialousa (delta 27(B9)Ala>Ser) is the most com-
mon δ-thal mutation in the Mediterranean Region and was 
first identified by Trifillis et al. in a Sardinian family in 
1991 [1,5]. HbA2-Yokoshima (delta 25(B7)Gly >Asp) was 
first identified in a Japanese family in which 1 member 
was homozygous [6]. 
Altay et al. reported the presence of abnormal hemoglo-
bin variants in their review, including a-globin, β-globin, 
and δ-globin variants [7]. In 2007 Akar et al. reported that 
there were 88 hemoglobin variants [8]. As most hemoglo-
bin variants are asymptomatic, they are often detected dur-
ing family and population studies, and premarital screen-
ing programs. As an example, during premarital screening 
in Denizli, Turkey, several variants of hemoglobin were 
observed and identified; Hb-Yaizu, Hb-Ouled Rabah, and 
Hb-Tunis were the first reported cases in Turkey [9,10].  
In total, the DNA of 12 β-thalassemia carriers with a 
low HbA2 level was studied. Written informed consent was 
obtained from the patients during donation of their DNA 
for use as anonymous samples. DNA amplification and 
sequencing were performed using a BECKMAN Coulter 
CEQ8000 non-radioactive fluorescence dye-based genetic 
analysis system, according to Pavlou et al. [11]. We iden-
tified IVS-1/nt-6 (T>C), IVS-1/nt-110 (G>A), IVS-2/nt-1 
(G>A), and Cd44 (-C) mutations in all the DNA samples. 
Only 3 of the 12 β-thal carriers had a low HbA2 level and 
δ-globin gene mutation. DNA sequencing showed that the 
mutation at δ-globin gene codon 25 (GGT/GAT) caused 
Hb-Yokoshima (Figure 1a) and mutation at δ-globin gene 
codon 27 (GCC/TCC) caused Hb-Yialousa (Figure 1b). All 
Figure 1: DNA sequencing of the HbA2-Yokoshima (a) and 
HbA2-Yialousa (b) cases.
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of the patients that carried δ-globin mutations also carried 
(β-thal) IVS-1-110 (G>A) mutation at the β-globin gene.  
In conclusion, we would like to emphasize the impor-
tance of HbA2 variants in premarital diagnosis, and that the 
presence of variants of this δ-globin resulting in decreased 
HbA2 expression could lead to misdiagnosis of β-thal car-
rier status. 
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